January 17, 2014
West Virginia legislative committee approves whistleblower law
West Virginia is considering a legislative proposal to enact a false claim law that would protect and reward whistleblowers with information about fraud against the state. The West Virginia House Judiciary...
Posted In Whistleblower Law Insights
December 27, 2013
Qui tam cases helped recover $2.9 billion in 2013
The federal government recovered more than $3.8 billion in fiscal year 2013 from False Claims Act cases, in large part due to qui tam (whistleblower) cases, according to recent statistics released by the...
Posted In Whistleblower Law Insights
November 19, 2013
Phillips & Cohen attorney moderates webinar for judges on False Claims Act litigation
Phillips & Cohen partner Colette Matzzie today moderated a webinar for federal district and appellate judges on “Recurring Issues in False Claims Litigation,” sponsored by the Federal Judicial...
Posted In Whistleblower Law Insights
November 08, 2013
Sutter Health pays $46 million in case alleging false, misleading surgery bills
The effectiveness of the whistleblower reward program under the California Department of Insurance was demonstrated earlier this week when Sutter Health agreed to a $46 million settlement in a case alleging...
Posted In Whistleblower Law Insights
November 01, 2013
Medical device company unintentionally highlights the problem with doctor ownership
The coincidental timing of a new government report and a recent lawsuit show that some medical device companies just don’t get why it’s not a good idea for doctors to have financial arrangements with...
Posted In Whistleblower Law Insights
October 01, 2013
SEC makes good on promise for large whistleblower reward soon
The Securities and Exchange Commission (SEC) announced today that it has awarded $14 million to a whistleblower for information and assistance. This is the largest SEC whistleblower reward so far under...
September 27, 2013
JP Morgan settlement criticized
The Securities and Exchange Commission settlement of a case against JPMorgan without charging any top executives, was heavily criticized by Jesse Eisinger, a finance reporter for ProPublica in a New York...
September 23, 2013
FDA bans Ranbaxy imports – again – for pharma manufacturing concerns
For the third time in five years, the U.S. Food and Drug Administration has blocked imports of medicine from a Ranbaxy Laboratories Ltd. plant in India for manufacturing violations. The latest ban involves...
Posted In Whistleblower Law Insights
September 16, 2013
Vanderbilt University hospital accused of failing to supervise doctors and nurses in training during surgeries
A “qui tam” lawsuit against the Vanderbilt University Medical Center that was unsealed last week contained a particularly disturbing allegation: It cited an incident where an unsupervised student nurse...
Posted In Whistleblower Law Insights
September 13, 2013
Bayer AG is the latest pharma company to acknowledge it is being investigated by Chinese authorities for its marketing and sales practices in China
Given the growing number of pharma companies in China under investigation for bribery and corruption, it’s becoming more a question of who isn’t being investigated, rather than who is. Pharma companies...
Posted In Whistleblower Law Insights